[PDF][PDF] Guidelines for the management of thyroid cancer

P Perros, K Boelaert, S Colley, C Evans… - Clinical …, 2014 - thyroidcancercanada.org
BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Options to meet the future global demand of radionuclides for radionuclide therapy

T Das, MRA Pillai - Nuclear medicine and biology, 2013 - Elsevier
Nuclear medicine continues to represent one of the important modalities for cancer
management. While diagnostic nuclear medicine for cancer management is fairly well …

Radionuclide candidates for β+ γ coincidence PET: an overview

M Sitarz, JP Cussonneau, T Matulewicz… - Applied Radiation and …, 2020 - Elsevier
Following the advancement of the Positron Emission Tomography (PET), a novel technique
emerged which takes advantage of the gamma quanta emitted, in some cases, after the β+ …

[HTML][HTML] Incremental diagnostic value of [18F]tetrafluoroborate PET-CT compared to [131I]iodine scintigraphy in recurrent differentiated thyroid cancer

M Dittmann, JM Gonzalez Carvalho, K Rahbar… - European Journal of …, 2020 - Springer
Introduction Efficient therapy of recurrent differentiated thyroid cancer (DTC) is dependent on
precise molecular imaging techniques targeting the human sodium iodide symporter (hNIS) …

Outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure

J Willegaignon, M Sapienza, C Ono… - Clinical nuclear …, 2011 - journals.lww.com
Methods: In total, 100 patients were treated on an outpatient basis, taking into consideration
their acceptable living conditions, interests, and willingness to comply with medical and …

Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I) NaI, on an outpatient basis, be safe?

JWA de Carvalho, M Sapienza, C Ono… - Nuclear medicine …, 2009 - journals.lww.com
Objectives The first objective of this study was to evaluate the radiological impact on
relatives and the environment because of outpatient treatment of differentiated thyroid …

Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of …

M Prpic, N Dabelic, J Stanicic, T Jukic… - Annals of nuclear …, 2012 - Springer
Objective To assess efficiency of various I-131 activities on thyroid remnant ablation in
thyroid cancer patients. The significance of patients' characteristics, pathologic features and …

Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment

AN Al-Haj, CS Lagarde, AM Lobriguito - Health physics, 2007 - journals.lww.com
Patients administered with a therapeutic dose of 131 I for thyroid cancer treatment are
potential sources of unacceptably high radiation exposure to other individuals, particularly …

[HTML][HTML] Radiation exposure levels in family members of Omani patients with thyrotoxicosis treated with radioiodine (131I) as outpatients

I Al-Maskery, H Bererhi - Sultan Qaboos University Medical Journal, 2009 - ncbi.nlm.nih.gov
Objectives: This study was conducted to assess whether the radiation exposure levels of
Omani family members of thyrotoxic patients, if treated with radioiodine therapy as …

[PDF][PDF] A study of the time of hospital discharge of differentiated thyroid cancer patients after receiving iodine-131 for thyroid remnant ablation treatment

Z Azizmohammadi, F Tabei, B Shafiei, AA Babaei… - Hell J Nucl …, 2013 - researchgate.net
The aim of this study was to measure the radiation exposure rate from differentiated thyroid
carcinoma (DTC) patients who had received iodine-131 (131I) treatment, and to evaluate …